Australia's most trusted
source of pharma news
Tuesday, 26 November 2024
Posted 22 November 2024 AM
Roche has been voted the best Big Pharma for corporate reputation according to neurology patient groups, followed by Novartis in second place and Sanofi in third but industry as a whole has been called out for failing to invest enough in this therapeutic area.
According to the latest PatientView survey, the podium winners were the same for patients who were both 'familiar' with the companies and those who had 'worked' with them.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.